MetLife Investment Management
WGS icon

MetLife Investment Management’s GeneDx Holdings WGS Stock Holding History

MetLife Investment Management’s Portfolio WGS Stock Details WGS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$792K Buy
11,538
+718
+7% +$40.8K ﹤0.01% 1641
2026
Q1 		$695K Sell
10,820
-88
-0.8% -$8.02K ﹤0.01% 1594
2025
Q4 		$1.42M Hold
10,908
– – 0.01% 1239
2025
Q3 		$1.18M Sell
10,908
-381
-3% -$41.5K 0.01% 1348
2025
Q2 		$1.04M Buy
11,289
+3,650
+48% +$287K 0.01% 1291
2025
Q1 		$677K Sell
7,639
-111
-1% -$9.63K ﹤0.01% 1553
2024
Q4 		$596K Buy
7,750
+453
+6% +$31.6K ﹤0.01% 1708
2024
Q3 		$310K Buy
+7,297
New +$246K ﹤0.01% 2047
2022
Q3 		– Sell
-2,818
Closed -$117K – 2846
2022
Q2 		$117K Buy
+2,818
New +$191K ﹤0.01% 2649

Other funds holding WGS

Corvex Management
Corvex Management New York $3.27B AUM 38.53% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
ARK Investment Management
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

MetLife Investment Management's WGS Position: Q2 2026 in Review

MetLife Investment Management increased its GeneDx Holdings (WGS) stake by 6.6% in Q2 2026, buying an estimated $40.8K and bringing the position to 11,538 shares worth $792K. The position accounts for ﹤0.01% of the portfolio, ranked #1641.

MetLife Investment Management first reported a position in WGS in Q2 2022 and has held it in 9 quarters since. The position peaked at $1.42M in Q4 2025. 223 funds tracked by Wall St. Rank hold WGS as of Q2 2026.

  • MetLife Investment Management held 11,538 shares of GeneDx Holdings worth $792K as of Q2 2026.
  • MetLife Investment Management bought 718 GeneDx Holdings shares in Q2 2026, an estimated $40.8K.
  • GeneDx Holdings made up ﹤0.01% of MetLife Investment Management's portfolio in Q2 2026, its #1641 holding.
  • MetLife Investment Management first reported a position in GeneDx Holdings in Q2 2022 and has held it in 9 quarters since.
  • MetLife Investment Management's GeneDx Holdings position peaked at $1.42M in Q4 2025.
  • 223 funds tracked by Wall St. Rank held GeneDx Holdings as of Q2 2026.

Based on MetLife Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.